<DOC>
	<DOCNO>NCT02931214</DOCNO>
	<brief_summary>The purpose study evaluate safety pharmacokinetics single ascend IV dos GMI-1359 healthy adult subject .</brief_summary>
	<brief_title>Placebo-Controlled Single Dose Study Evaluate Safety Pharmacokinetics GMI-1359 Healthy Volunteers</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , single ascend IV dose study conduct one study center United States . Safety assess throughout study serial blood sample urine sample collect safety pharmacokinetic assessment GMI-1359 .</detailed_description>
	<criteria>1 . Healthy adult male female , 1960 year age ( inclusive ) . 2 . Medically healthy clinically significant screen result . 3 . Females childbearing potential must either sexually inactive ( abstinent ) 3 month prior dose use acceptable birth control method 4 . Females must negative pregnancy test time screen prior dose inclusion study . 5 . Understands study procedure inform consent form , willing able comply protocol . 1 . Subject mentally legally incapacitate . 2 . History illness , opinion PI , might confound result study pose additional risk subject participation study . 3 . Normal clinical laboratory value . 4 . Normal heart rate blood pressure . 5 . Blood donation significant blood loss within 56 day prior dose . 6 . Plasma donation within 7 day prior dose . 7 . Participation another clinical trial within 28 day prior dose .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Healthy Subjects</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>